CBT
Price
$79.00
Change
-$2.47 (-3.03%)
Updated
Sep 12 closing price
Capitalization
4.2B
58 days until earnings call
SCL
Price
$48.11
Change
-$1.40 (-2.83%)
Updated
Sep 12 closing price
Capitalization
1.09B
31 days until earnings call
Interact to see
Advertisement

CBT vs SCL

Header iconCBT vs SCL Comparison
Open Charts CBT vs SCLBanner chart's image
Cabot
Price$79.00
Change-$2.47 (-3.03%)
Volume$317.28K
Capitalization4.2B
Stepan
Price$48.11
Change-$1.40 (-2.83%)
Volume$82.56K
Capitalization1.09B
CBT vs SCL Comparison Chart in %
Loading...
CBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBT vs. SCL commentary
Sep 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBT is a Buy and SCL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 14, 2025
Stock price -- (CBT: $79.00 vs. SCL: $48.11)
Brand notoriety: CBT and SCL are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: CBT: 89% vs. SCL: 57%
Market capitalization -- CBT: $4.2B vs. SCL: $1.09B
CBT [@Chemicals: Specialty] is valued at $4.2B. SCL’s [@Chemicals: Specialty] market capitalization is $1.09B. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $226.03B to $0. The average market capitalization across the [@Chemicals: Specialty] industry is $9.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBT’s FA Score shows that 1 FA rating(s) are green whileSCL’s FA Score has 1 green FA rating(s).

  • CBT’s FA Score: 1 green, 4 red.
  • SCL’s FA Score: 1 green, 4 red.
According to our system of comparison, CBT is a better buy in the long-term than SCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBT’s TA Score shows that 6 TA indicator(s) are bullish while SCL’s TA Score has 4 bullish TA indicator(s).

  • CBT’s TA Score: 6 bullish, 3 bearish.
  • SCL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CBT is a better buy in the short-term than SCL.

Price Growth

CBT (@Chemicals: Specialty) experienced а -2.53% price change this week, while SCL (@Chemicals: Specialty) price change was -4.07% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +0.37%. For the same industry, the average monthly price growth was +0.55%, and the average quarterly price growth was +11.19%.

Reported Earning Dates

CBT is expected to report earnings on Nov 10, 2025.

SCL is expected to report earnings on Oct 15, 2025.

Industries' Descriptions

@Chemicals: Specialty (+0.37% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CBT($4.2B) has a higher market cap than SCL($1.09B). SCL has higher P/E ratio than CBT: SCL (18.94) vs CBT (10.34). CBT YTD gains are higher at: -12.036 vs. SCL (-24.071). CBT has higher annual earnings (EBITDA): 811M vs. SCL (204M). CBT has more cash in the bank: 239M vs. SCL (88.9M). SCL has less debt than CBT: SCL (708M) vs CBT (1.22B). CBT has higher revenues than SCL: CBT (3.82B) vs SCL (2.26B).
CBTSCLCBT / SCL
Capitalization4.2B1.09B386%
EBITDA811M204M398%
Gain YTD-12.036-24.07150%
P/E Ratio10.3418.9455%
Revenue3.82B2.26B169%
Total Cash239M88.9M269%
Total Debt1.22B708M172%
FUNDAMENTALS RATINGS
CBT vs SCL: Fundamental Ratings
CBT
SCL
OUTLOOK RATING
1..100
1080
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
44100
SMR RATING
1..100
3386
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
7097
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBT's Valuation (50) in the Industrial Specialties industry is in the same range as SCL (50) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to SCL’s over the last 12 months.

CBT's Profit vs Risk Rating (44) in the Industrial Specialties industry is somewhat better than the same rating for SCL (100) in the Chemicals Specialty industry. This means that CBT’s stock grew somewhat faster than SCL’s over the last 12 months.

CBT's SMR Rating (33) in the Industrial Specialties industry is somewhat better than the same rating for SCL (86) in the Chemicals Specialty industry. This means that CBT’s stock grew somewhat faster than SCL’s over the last 12 months.

CBT's Price Growth Rating (50) in the Industrial Specialties industry is in the same range as SCL (50) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to SCL’s over the last 12 months.

CBT's P/E Growth Rating (70) in the Industrial Specialties industry is in the same range as SCL (97) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to SCL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBTSCL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 6 days ago
68%
Bullish Trend 9 days ago
52%
Declines
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 4 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
CBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNCSX21.58-0.03
-0.14%
Hartford International Growth R4
TCIHX27.51-0.12
-0.43%
Nuveen International Eq Idx I
GGORX10.87-0.10
-0.91%
Goldman Sachs Mid Cap Growth R
JAVTX85.29-0.92
-1.07%
Janus Henderson Venture T
RYOIX71.39-1.18
-1.63%
Rydex Biotechnology Inv

CBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBT has been closely correlated with SCL. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CBT jumps, then SCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBT
1D Price
Change %
CBT100%
-3.03%
SCL - CBT
69%
Closely correlated
-2.83%
WLK - CBT
68%
Closely correlated
-1.62%
FUL - CBT
68%
Closely correlated
-3.31%
AVNT - CBT
67%
Closely correlated
-3.00%
KWR - CBT
67%
Closely correlated
-0.43%
More

SCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCL has been closely correlated with IOSP. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCL jumps, then IOSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCL
1D Price
Change %
SCL100%
-2.83%
IOSP - SCL
76%
Closely correlated
-1.15%
AVNT - SCL
75%
Closely correlated
-3.00%
KWR - SCL
75%
Closely correlated
-0.43%
OLN - SCL
73%
Closely correlated
-2.04%
FUL - SCL
69%
Closely correlated
-3.31%
More